1. Home
  2. PCRX vs LEG Comparison

PCRX vs LEG Comparison

Compare PCRX & LEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • LEG
  • Stock Information
  • Founded
  • PCRX 2006
  • LEG 1883
  • Country
  • PCRX United States
  • LEG United States
  • Employees
  • PCRX N/A
  • LEG N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • LEG Home Furnishings
  • Sector
  • PCRX Health Care
  • LEG Consumer Discretionary
  • Exchange
  • PCRX Nasdaq
  • LEG Nasdaq
  • Market Cap
  • PCRX 1.2B
  • LEG 1.2B
  • IPO Year
  • PCRX 2011
  • LEG N/A
  • Fundamental
  • Price
  • PCRX $21.85
  • LEG $8.81
  • Analyst Decision
  • PCRX Buy
  • LEG Hold
  • Analyst Count
  • PCRX 5
  • LEG 4
  • Target Price
  • PCRX $32.40
  • LEG $10.00
  • AVG Volume (30 Days)
  • PCRX 577.9K
  • LEG 1.7M
  • Earning Date
  • PCRX 11-06-2025
  • LEG 10-27-2025
  • Dividend Yield
  • PCRX N/A
  • LEG 2.27%
  • EPS Growth
  • PCRX N/A
  • LEG N/A
  • EPS
  • PCRX N/A
  • LEG 1.61
  • Revenue
  • PCRX $705,848,000.00
  • LEG $4,172,899,999.00
  • Revenue This Year
  • PCRX $7.27
  • LEG N/A
  • Revenue Next Year
  • PCRX $10.18
  • LEG N/A
  • P/E Ratio
  • PCRX N/A
  • LEG $5.47
  • Revenue Growth
  • PCRX 2.25
  • LEG N/A
  • 52 Week Low
  • PCRX $16.00
  • LEG $6.48
  • 52 Week High
  • PCRX $27.64
  • LEG $13.20
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 41.81
  • LEG 44.41
  • Support Level
  • PCRX $21.20
  • LEG $9.07
  • Resistance Level
  • PCRX $22.74
  • LEG $10.73
  • Average True Range (ATR)
  • PCRX 0.96
  • LEG 0.37
  • MACD
  • PCRX 0.14
  • LEG -0.04
  • Stochastic Oscillator
  • PCRX 59.08
  • LEG 9.22

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About LEG Leggett & Platt Incorporated

Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the majority of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.

Share on Social Networks: